There is not enough irrefutable evidence that dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists have positive effects on cognition in patients with type 2 diabetes mellitus (T2DM), according to a study.
Regular supplementation with low-dose resveratrol in postmenopausal women helps improve cognitive function, as well as alleviate chronic pain due to age-related osteoarthritis, according to data from the Resveratrol for Healthy Ageing in Women study.
A history of cerebrovascular disease increases the risk of mortality in patients with the novel coronavirus disease (COVID-19) by 2.78-fold when compared to those with other comorbidities or without underlying pathologies, reveal the results of a recent study.
Internet-delivered cognitive behavioural therapy (CBT) benefits younger adolescents the most, a recent study has found. Those whose parents have low levels of emotional distress seem to likewise benefit more from CBT over the internet.
In stroke rehabilitation, performing aerobic and stepping exercises at a higher intensity and frequency within a critical time period can boost the recovery and improve the quality of life of patients, according to the results of a phase II trial.
Early parenting intervention, particularly the Attachment and Biobehavioral Catch-Up (ABC), has been shown to enhance brain regions that support children’s social cognitive development, according to a recent study.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).